Definition
The observable physical and biochemical characteristics of an organism or cell that result from the interaction of its genotype with the environment.
The observable physical and biochemical characteristics of organisms or cells that result from the interaction of their genotypes with the environment.
Observable characteristics or properties of a cell or organism determined by its genotype and environment.
Related Claims
- Aneuploidy impairs cell cycle progression in haploid yeast
- Extra chromosome genes drive aneuploid phenotypes through imbalanced protein composition
- Aneuploidy exhibits dual roles as oncogenic and tumor-suppressive
- Copy number-independent gene expression differences exist in glioblastoma CSCs
- Copy number-independent gene signature correlates with tumor grade and patient survival
- Mps1 truncation-induced CIN generates convergent recurrent chromosome gains
Synthesis
Across all sources, phenotype is consistently established as the observable characteristics or traits of an organism or cell that emerge from the interaction between genotype and environmental factors. The mechanistic relationships emphasize that phenotypes arise through multiple pathways: direct gene dosage effects from copy number alterations, transcriptional changes that occur independently of copy number variations, and systemic cellular stresses such as the proteotoxic imbalance caused by aneuploidy. Notably, studies demonstrate that similar phenotypic outcomes can result from different genetic perturbations—for example, diverse aneuploid yeast strains carrying different extra chromosomes converge on shared phenotypes including cell cycle defects and reduced cellular fitness, suggesting a general mechanism of chromosomal imbalance stress rather than chromosome-specific effects. What remains contested is the relative contribution and context-dependence of these mechanisms, particularly the paradoxical dual nature of aneuploidy as both tumor-promoting and tumor-suppressive depending on cellular context, and the extent to which copy number-independent transcriptional changes versus direct dosage effects drive clinically relevant phenotypes in diseases like glioblastoma.